Checkpoint Inhibitors in Neuro-oncology

Checkpoint inhibitors are a type of cancer treatment that help the immune system recognize and attack cancer cells. They work by blocking proteins on immune cells or cancer cells that usually prevent the immune system from working effectively. In neuro-oncology, which focuses on brain and spinal cord tumors, these therapies can boost the body’s immune response against aggressive tumors like glioblastomas. Although promising, their effectiveness can vary, and they may not be suitable for all patients. Ongoing research is needed to better understand how to use these treatments for brain cancers.